Therefore, the glycosylation of PD-1 may not only affect the immune regulatory roles of the MAbs targeting PD-1 in T cells but may also interfere with the tumor regulatory roles of the MAbs when binding to PD-1 in tumor cells. This evidence concerns the gene PDCD1 and neoplasm.